These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12045496)

  • 1. Discordant responses during antiretroviral therapy: role of immune activation and T cell redistribution rather than true CD4 T cell loss.
    Hazenberg MD; Otto SA; Wit FW; Lange JM; Hamann D; Miedema F
    AIDS; 2002 Jun; 16(9):1287-9. PubMed ID: 12045496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discordant movement of CD4-positive T-cell count in HIV-1 infected patients with HAART failure.
    Okano A; Matsuda M; Chiba T; Moriya K; Yamada K; Sugiura W
    Jpn J Infect Dis; 2002 Apr; 55(2):62-5. PubMed ID: 12082315
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection.
    Kaufmann GR; Zaunders JJ; Cunningham P; Kelleher AD; Grey P; Smith D; Carr A; Cooper DA
    AIDS; 2000 Dec; 14(17):2643-51. PubMed ID: 11125882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple CD4+ cell kinetic patterns and their relationships with baseline factors and virological responses in HIV type 1 patients receiving highly active antiretroviral therapy.
    Wu H; Connick E; Kuritzkes DR; Landay A; Spritzler J; Zhang B; Spear GT; Kessler H; Lederman MM;
    AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1231-40. PubMed ID: 11559422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy.
    Kaufmann GR; Bloch M; Zaunders JJ; Smith D; Cooper DA
    AIDS; 2000 May; 14(8):959-69. PubMed ID: 10853977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy.
    Hunt PW; Martin JN; Sinclair E; Bredt B; Hagos E; Lampiris H; Deeks SG
    J Infect Dis; 2003 May; 187(10):1534-43. PubMed ID: 12721933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
    Gray CM; Schapiro JM; Winters MA; Merigan TC
    AIDS Res Hum Retroviruses; 1998 May; 14(7):561-9. PubMed ID: 9591710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordant outcomes following failure of antiretroviral therapy are associated with substantial differences in human immunodeficiency virus-specific cellular immunity.
    Price DA; Scullard G; Oxenius A; Braganza R; Beddows SA; Kazmi S; Clarke JR; Johnson GE; Weber JN; Phillips RE
    J Virol; 2003 May; 77(10):6041-9. PubMed ID: 12719595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune correlates of virological response in HIV-positive patients after highly active antiretroviral therapy (HAART).
    Torti C; Cologni G; Uccelli MC; Quiros-Roldan E; Imberti L; Airó P; Pirovano S; Patroni A; Tirelli V; Carosi G
    Viral Immunol; 2004; 17(2):279-86. PubMed ID: 15279705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower CD4+ T lymphocyte nadirs may indicate limited immune reconstitution in HIV-1 infected individuals on potent antiretroviral therapy: analysis of immunophenotypic marker results of AACTG 5067.
    D'Amico R; Yang Y; Mildvan D; Evans SR; Schnizlein-Bick CT; Hafner R; Webb N; Basar M; Zackin R; Jacobson MA
    J Clin Immunol; 2005 Mar; 25(2):106-15. PubMed ID: 15821887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-15 production by monocyte-derived dendritic cells and T cell proliferation in HIV-infected patients with discordant response to highly active antiretroviral therapy.
    d'Ettorre G; Forcina G; Andreotti M; Sarmati L; Palmisano L; Andreoni M; Vella S; Mastroianni CM; Vullo V
    Clin Exp Immunol; 2004 Feb; 135(2):280-5. PubMed ID: 14738457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discordant immunological and virological responses to antiretroviral therapy.
    Schechter M; Tuboi SH
    J Antimicrob Chemother; 2006 Sep; 58(3):506-10. PubMed ID: 16854959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly active antiretroviral therapy restores in vitro mitogen and antigen-specific T-lymphocyte responses in HIV-1 perinatally infected children despite virological failure.
    Peruzzi M; Azzari C; Galli L; Vierucci A; De Martino M
    Clin Exp Immunol; 2002 May; 128(2):365-71. PubMed ID: 11985529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of prolonged discontinuation of successful antiretroviral therapy on CD4+ T cell decline in human immunodeficiency virus-infected patients: implications for intermittent therapeutic strategies.
    Tebas P; Henry K; Mondy K; Deeks S; Valdez H; Cohen C; Powderly WG
    J Infect Dis; 2002 Sep; 186(6):851-4. PubMed ID: 12198623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy.
    Yukl SA; Gianella S; Sinclair E; Epling L; Li Q; Duan L; Choi AL; Girling V; Ho T; Li P; Fujimoto K; Lampiris H; Hare CB; Pandori M; Haase AT; Günthard HF; Fischer M; Shergill AK; McQuaid K; Havlir DV; Wong JK
    J Infect Dis; 2010 Nov; 202(10):1553-61. PubMed ID: 20939732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphoma.
    Powles T; Imami N; Nelson M; Gazzard BG; Bower M
    AIDS; 2002 Mar; 16(4):531-6. PubMed ID: 11872995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-2 Increases CD4+ lymphocyte numbers but does not enhance responses to immunization: results of A5046s.
    Valdez H; Mitsuyasu R; Landay A; Sevin AD; Chan ES; Spritzler J; Kalams SA; Pollard RB; Fahey J; Fox L; Namkung A; Estep S; Moss R; Sahner D; Lederman MM
    J Infect Dis; 2003 Jan; 187(2):320-5. PubMed ID: 12552459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological and virological failure after antiretroviral therapy is associated with enhanced peripheral and thymic pathogenicity.
    Solomon A; Cameron PU; Bailey M; Dunne AL; Crowe SM; Hoy JF; Lewin SR
    J Infect Dis; 2003 Jun; 187(12):1915-23. PubMed ID: 12792868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection.
    Hecht FM; Wang L; Collier A; Little S; Markowitz M; Margolick J; Kilby JM; Daar E; Conway B; Holte S;
    J Infect Dis; 2006 Sep; 194(6):725-33. PubMed ID: 16941337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during suppressive HAART.
    Massanella M; Negredo E; Pérez-Alvarez N; Puig J; Ruiz-Hernández R; Bofill M; Clotet B; Blanco J
    AIDS; 2010 Apr; 24(7):959-68. PubMed ID: 20177358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.